Daily Current Affairs 2025, Date wise Current Affairs | Current Affairs in English and Hindi

Get the Daily and Latest Current Affairs 2025 on our website. These current affairs are Updated by our specialists and are relevant for all competitive tests UPSC, SSC, IAS, Railway-RRB, UPPSC, and Other State Government and Central Jobs/Exams.


India’s first mRNA-based Omicron-specific booster vaccine approved

Category : National
Published on: June 24 2023 Share on facebook

  • India’s first indigenous mRNA vaccine for the Omicron variant, GEMCOVAC-OM, developed by Pune-based Gennova Biopharmaceuticals Ltd, was approved under emergency use guidelines by the Drug Controller General of India .
  • This comes a year after the company got approval for GEMCOVAC-19, the country’s first m-RNA vaccine against COVID-19.
  • The vaccine is the first booster Covid-19 vaccine developed in India against the highly transmissible Omicron variant and has demonstrated robust immune responses in phase 3 clinical trials. 
  • It is stable at two to eight degrees Centigrade and has been developed using Gennova's indigenous platform technology, supported under 'Mission Covid Suraksha'.
  • The Indian ‘Covid-19 Vaccine Development Mission’ by DBT’s dedicated mission implementation unit at BIRAC, for further clinical development and scale-up of the prototype vaccine, which received EUA on June 29, 2022.”
Recent Post's